CLEARBRIDGE INVESTMENTS, LLC – Ultragenyx Pharmaceutical Inc. Transaction History
CLEARBRIDGE INVESTMENTS, LLC portfolio value:
$114.40M
portfolio value
CLEARBRIDGE INVESTMENTS, LLC quarter portfolio value change:
-30.59%
quarter
Ultragenyx Pharmaceutical Inc. 13F transactions
| Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
|---|---|---|---|---|---|---|---|
| Q3 2022 | share | Decrease | -2.62% | -74.32K shares | -54.85M | $41.41 | 2.76M |
| Q2 2022 | share | Decrease | -0.94% | -26.77K shares | -38.71M | $59.66 | 2.83M |
| Q1 2022 | share | Increase | +3.06% | 85.06K shares | -25.69M | $72.62 | 2.86M |
| Q4 2021 | share | Increase | +17.47% | 413.23K shares | 20.31M | $84.25 | 2.77M |
| Q3 2021 | share | Decrease | -0.21% | -4.89K shares | -12.67M | $90.19 | 2.36M |
| Q2 2021 | share | Increase | +24.54% | 467.12K shares | 9.30M | $95.35 | 2.37M |
| Q1 2021 | share | Increase | +1.50% | 28.07K shares | -42.87M | $113.86 | 1.90M |
| Q4 2020 | share | Increase | +5.42% | 96.33K shares | 113.38M | $138.43 | 1.87M |
| Q3 2020 | share | Increase | +0.70% | 12.41K shares | 8.03M | $82.19 | 1.77M |
| Q2 2020 | share | Increase | +43.70% | 537.25K shares | 83.56M | $78.22 | 1.76M |
| Q1 2020 | share | Increase | +4.55% | 53.53K shares | 3.93M | $44.43 | 1.22M |
| Q4 2019 | share | Decrease | -14.91% | -206.00K shares | -8.42M | $42.71 | 1.17M |
| Q3 2019 | share | Increase | +37.10% | 373.90K shares | -4.88M | $42.78 | 1.38M |
| Q2 2019 | share | Decrease | -0.53% | -5.4K shares | -6.28M | $63.5 | 1.00M |
| Q1 2019 | share | Increase | +0.32% | 3.23K shares | 26.36M | $69.36 | 1.01M |
| Q4 2018 | share | Increase | +0.02% | 164 shares | -33.17M | $43.48 | 1.01M |
| Q3 2018 | share | Increase | +5.59% | 53.46K shares | 3.57M | $76.34 | 1.00M |
| Q2 2018 | share | Increase | +20.37% | 161.82K shares | 33.00M | $76.87 | 956.41K |
| Q1 2018 | share | Increase | +17877.10% | 790.16K shares | 40.31M | $50.99 | 794.58K |
| Q4 2017 | share | Decrease | -0.11% | -5 shares | -31K | $46.38 | 4.42K |
| Q3 2017 | share | Increase | +0.64% | 28 shares | -37K | $53.26 | 4.42K |
| Q2 2017 | share | Increase | +58.45% | 1.62K shares | 85K | $62.11 | 4.39K |
| Q1 2017 | share | Decrease | -1.25% | -35 shares | -10K | $67.78 | 2.77K |
| Q4 2016 | share | Increase | +2.93% | 80 shares | 4K | $70.31 | 2.81K |
| Q3 2016 | share | Decrease | -0.07% | -2 shares | 60K | $70.94 | 2.73K |
| Q2 2016 | share | Increase | +123.57% | 1.51K shares | 57K | $48.91 | 2.73K |
| Q1 2016 | share | Increase | +618.82% | 1.05K shares | 58K | $63.31 | 1.22K |